Donald W. Wyatt
Founder bij The Wyatt Group LLC
Profiel
Donald W.
Wyatt founded The Wyatt Group LLC in 2009, where he is working as Principal from 2013.
Mr. Wyatt also formerly worked at Isotechnika Pharma, Inc., as Independent Non-Executive Director from 2012 to 2013, Aurinia Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, and CTI BioPharma Corp., as Secretary.
Mr. Wyatt received his graduate degree from Hampshire College.
Actieve functies van Donald W. Wyatt
| Bedrijven | Functie | Begin |
|---|---|---|
| The Wyatt Group LLC | Founder | 01-01-2009 |
Eerdere bekende functies van Donald W. Wyatt
| Bedrijven | Functie | Einde |
|---|---|---|
Isotechnika Pharma, Inc.
 Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Director/Board Member | 23-10-2013 |
| AURINIA PHARMACEUTICALS INC. | Director/Board Member | - |
| CTI BIOPHARMA CORP. | Corporate Secretary | - |
Opleiding van Donald W. Wyatt
| Hampshire College | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Isotechnika Pharma, Inc. is a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics. Its products include voclosporin and non-immunosuppressive cyclosporine analogue molecules. The company was founded by Robert T. Foster founded on June 16, 1993 and is headquartered in Edmonton, Canada. | Health Technology |
| The Wyatt Group LLC | Miscellaneous |
